K
Knowledge Palette
Biotech startup advancing regenerative medicine with high-precision gene analysis for robust cell manufacturing
About Knowledge Palette
Knowledge Palette is a biotechnology startup focused on advancing regenerative medicine through high-precision gene analysis and robust cell manufacturing. The company primarily serves the healthcare and medical research sectors, collaborating with organizations like Celaid Therapeutics to enhance the understanding of cell characteristics using single-cell transcriptome technology. Operating in the biotech market, Knowledge Palette employs a business model centered on research and development, generating revenue through collaborative research contracts and funding rounds, such as their recent Series B financing from Zeon Corporation. The company leverages its expertise in biotechnology, AI, and data science to develop innovative solutions for regenerative medicine, aiming to cure illnesses with living cells.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Kawasaki, Japan
- Sector
- Spinout
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Sparx Group
ANRI
Bank of Yokohama
Zeon
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Knowledge Palette on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Knowledge Palette on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.